ArticleCureus2026
Hepatic Steatosis Complicating Pediatric Idiopathic Nephrotic Syndrome During Systemic Corticosteroid Therapy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic steatosis is a rare complication of pediatric idiopathic nephrotic syndrome, and its clinical course has infrequently been described. A 22-month-old boy presented with generalized edema, oliguria, and massive proteinuria and was diagnosed with idiopathic nephrotic syndrome complicated by urinary tract infection. Following infection control, prednisolone was initiated according to the International Study of Kidney Disease in Children regimen, and complete remission was achieved by day 17. Serum aminotransferase levels increased on day 19, followed by progressive hepatomegaly. Abdominal ultrasonography revealed mild hepatic steatosis (score 1) on day 28, which progressed to severe steatosis (score 3) by day 45 despite improving serum lipid and aminotransferase levels. Noncontrast computed tomography on day 37 revealed hepatomegaly with decreased hepatic attenuation. A workup for secondary causes of steatosis was unremarkable. Following prednisolone tapering and discontinuation, hepatomegaly resolved by day 64, and hepatic steatosis gradually improved, with normalization confirmed on ultrasonography on day 246. The nephrotic syndrome has not recurred for more than five years after corticosteroid withdrawal. Hepatic steatosis may develop during corticosteroid treatment for pediatric idiopathic nephrotic syndrome, potentially owing to nephrotic hyperlipidemia and/or corticosteroid exposure. Ultrasonographic recovery may lag behind clinical remission and may take several months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.